Financials
- Market Capitalization 1.9 B
- Employee 87
- Founded 2018
- CEO N/A
- Website www.tyra.bio
- Headquarter Delaware, United States
- FIGI BBG00RCQD9D1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.08
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1991 | SION Sionna Therapeutics, Inc. - Common Stock | 43.51 USD | -1.00% | -0.62% | +19.07% | +10.60% | 1.96 B USD | ||
| 2000 | VRDN Viridian Therapeutics, Inc. - Common Stock | 19.10 USD | +0.58% | -2.05% | +15.20% | -14.92% | 1.97 B USD | ||
| 2012 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.64 USD | +1.32% | -2.00% | +19.27% | +109.75% | 1.96 B USD | ||
| 2014 | URGN UroGen Pharma Ltd. - Ordinary Shares | 39.55 USD | +0.10% | +6.00% | +33.84% | +108.16% | 1.93 B USD |